Infantile Hemangioma Clinical Trial
Official title:
Optical Tomographic Imaging of Infantile Hemangiomas
The investigators hypothesize that there are differences between infantile hemangiomas (IH) during the proliferating and involuting phases and in response to medical treatment that can be detected by optical tomography of these hemangiomas.
Infantile hemangiomas (IH) are common vascular growths that frequently arise in infants. The
clinical presentation is variable, and some hemangiomas have the potential to cause
disfiguring and even lifethreatening complications. While there is no FDA approved treatment
for IH, certain medications have been shown to be effective in shrinking the growths.
Unfortunately, there is no objective tool to monitor IH or to guide treatment. Such a tool
would improve the management of these patients. A new handheld wireless device uses diffuse
optical imaging (DOI) technology to measure blood flow characteristics.
The device has been used in studies to assess patients with breast cancer. Optical tomography
has also been increasingly used to assess neurological function and pathology in newborn
infants.
The goal of the investigators' study is to assess the utility of DOI for characterizing and
monitoring IH. Fifteen IH will be assessed at three points in time as part of this study,
comprising two groups: 'Natural History' and 'Treatment'. DOI measurements will be correlated
with clinical findings and existing ultrasound measurements of the IH.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02505971 -
Nadolol Versus Propranolol in Children With Infantile Hemangiomas
|
Phase 3 | |
| Recruiting |
NCT04288700 -
Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma
|
Phase 4 | |
| Completed |
NCT01431326 -
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
|
||
| Completed |
NCT01010308 -
Nadolol for Proliferating Infantile Hemangiomas
|
Phase 2 | |
| Completed |
NCT02913612 -
Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)
|
Phase 2 | |
| Recruiting |
NCT03237637 -
Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas
|
Phase 3 | |
| Recruiting |
NCT05479123 -
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
|
Phase 4 | |
| Terminated |
NCT01434849 -
Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)
|
Phase 1 | |
| Completed |
NCT04105517 -
Hemangiol, Post Marketing Surveillance Study
|
||
| Completed |
NCT01512173 -
Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo
|
Phase 2 | |
| Completed |
NCT01056341 -
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04684667 -
''Efficacy of Propranolol in the Treatment of Infantile Hemangioma"
|
Phase 2 | |
| Recruiting |
NCT03842631 -
Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination
|
||
| Recruiting |
NCT03173352 -
A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in China
|
N/A |